Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −4,596 $36.63 $168K 77,112
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −4,123 $37.38 $154K 72,989
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −600 $38.63 $23K 72,389
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −733 $39.66 $29K 71,656
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −600 $40.62 $24K 71,056
2018-02-09 Turner Heather D Former EVP, GC & Sec. Sale −1,562 $41.69 $65K 69,494
2018-02-09 Clark Mitchall G. EVP & Chief R & QA Officer Shares withheld for taxes −3,704 $41.70 $154K 179,913
2018-02-09 Haqq Christopher EVP, R&D & Chief Scientific Of Shares withheld for taxes −4,925 $41.70 $205K 350,679
2018-02-09 Soffer Gad EVP & Chief Strategy Officer Shares withheld for taxes −4,169 $41.70 $174K 265,580
2018-02-09 MCGRATH JOHN EVP & Chief Financial Officer Shares withheld for taxes −4,819 $41.70 $201K 105,556
2018-02-09 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $36.59 $80K 285,078
2018-02-09 Ciechanover Isaac E. Chief Executive Officer Sale −1,100 $37.43 $41K 283,978
2018-02-09 Ciechanover Isaac E. Chief Executive Officer Sale −400 $38.68 $15K 283,578
2018-02-09 Ciechanover Isaac E. Chief Executive Officer Sale −400 $40.79 $16K 283,178
2018-02-09 Ciechanover Isaac E. Chief Executive Officer Sale −300 $41.70 $13K 282,878
2018-02-08 Ciechanover Isaac E. Chief Executive Officer Sale −4,400 $37.15 $163K 287,278
2018-02-06 Turner Heather D EVP, General Counsel & Sec. Shares withheld for taxes −4,434 $35.80 $159K 81,708
2018-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Grant or award +17,500 360,030
2018-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Shares withheld for taxes −4,426 $35.80 $158K 355,604
2018-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000

Page 36 of 44 · 867 trades